FDA Inspection 1297264 — Smithfield Bioscience Inc
The FDA completed an inspection of Smithfield Bioscience Inc on Dec 23, 2025 in Cincinnati, OH. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Dec 23, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cincinnati, OH (United States)